{"success":true,"data":{"pressRelease":{"id":"53186","rtpr_id":"nWkr97BtFh","ticker":"ZZB","exchange":"Nasdaq Stockholm","all_tickers":["ZZB"],"title":"ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT MAY 2026","author":"Cision","published_at":"2026-06-03T07:00:15.988Z","article_body":"Zinzino\nZinzino group revenue increased with a total of 14 %, compared with the\nprevious year.\n\n \n\nThe revenue in May for Zinzino's sales markets increased by 14 % and amounted\nto SEK 312.2 (273.7) million. Faun Pharma's external sales amounted to SEK 3.9\n(3.9) million. Overall, the Group increased revenues by 14 % to SEK 316.1\n(277.6) million compared with the previous year.\n\nAccumulated revenue for January - May 2026 increased by 23 % to SEK 1,545.9\n(1,254.0) million.\n\n \n\nRevenues were distributed as follows:\n\n Regions,MSEK         26-May  25-May  Change  YTD 2026  YTD 2025  Change  \n The Nordics          26.2    29.5    -11%    129.4     129.8     0%      \n Central Europe       99.2    72.8    36%     464.4     333.9     39%     \n East Europe          30.1    36.3    -17%    141.6     160.6     -12%    \n South & West Europe  51.1    47.6    7%      258.5     216.4     19%     \n The Baltics          9.2     11.3    -19%    48.1      48.6      -1%     \n North America        66.6    46.1    44%     329.3     207.9     58%     \n South America        3.6     0.8     350%    18.7      3.9       379%    \n Asia-Pacific         24.1    27.4    -12%    117.2     118.4     -1%     \n Africa               2.1     1.9     11%     10.5      8.4       25%     \n Zinzino              312.2   273.7   14%     1,517.7   1,227.9   24%     \n Faun Pharma          3.9     3.9     0%      28.2      26.1      8%      \n Zinzino Group        316.1   277.6   14%     1,545.9   1,254.0   23%     \n\n \n\nCountries in regions:\n\n-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden\n\n-Central Europe: Austria, Germany, Switzerland\n\n-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania\n\n-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta,\nNetherlands, Slovenia, Portugal, Spain, United Kingdom, Belgium, Ireland,\nSerbia, Turkey, Canary Islands\n\n-The Baltics: Estonia, Latvia, Lithuania\n\n-North America: Canada, USA, Mexico\n\n-South America: Peru, Colombia\n\n-Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore,\nTaiwan, Thailand, China, Philippines, South Korea\n\n-Africa: South Africa\n\n \n\n \n\nFor more information:\n\nDag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com\n\nFredrik Nielsen CFO Zinzino +46 (0) 707 900 174, fredrik.nielsen@zinzino.com\n\n \n\nPictures for publication free of charge: marketing@zinzino.com\n\n \n\nCertified Adviser: Tapper Partners AB\n\nZinzino is a global health tech company from Scandinavia, pioneering a new\nstandard in personal health through advanced home health tests and\nscientifically proven nutritional supplements. Listed on the Nasdaq First\nNorth Premier Growth Market, the company's test-based, personalized nutrition\nstrategy empowers individuals to take charge of their long-term health with\nscience-based insights and targeted solutions. Its third-party validated\nproducts are available through direct sales distributors in more than 100\nmarkets worldwide. Zinzino's headquarters are located in Gothenburg, Sweden,\nwith additional offices across Europe, Asia, and Australia.\n\nhttps://news.cision.com/zinzino/r/zinzino-ab--publ--preliminary-sales-report-may-2026%2Cc4356932\n\n2605 Press release Sales report EN\n(https://mb.cision.com/Public/10976/4356932/abca147d59e4d6a7.pdf)\n\n\n\n(c) Copyright Waymaker BIT News - Cision 2026","article_body_html":"","raw_payload":{"data":{"id":"nWkr97BtFh","title":"ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT MAY 2026","author":"Cision","ticker":"ZZB","created":"2026-06-03T07:00:15.988Z","tickers":["ZZB"],"exchange":"Nasdaq Stockholm","article_body":"Zinzino\nZinzino group revenue increased with a total of 14 %, compared with the\nprevious year.\n\n \n\nThe revenue in May for Zinzino's sales markets increased by 14 % and amounted\nto SEK 312.2 (273.7) million. Faun Pharma's external sales amounted to SEK 3.9\n(3.9) million. Overall, the Group increased revenues by 14 % to SEK 316.1\n(277.6) million compared with the previous year.\n\nAccumulated revenue for January - May 2026 increased by 23 % to SEK 1,545.9\n(1,254.0) million.\n\n \n\nRevenues were distributed as follows:\n\n Regions,MSEK         26-May  25-May  Change  YTD 2026  YTD 2025  Change  \n The Nordics          26.2    29.5    -11%    129.4     129.8     0%      \n Central Europe       99.2    72.8    36%     464.4     333.9     39%     \n East Europe          30.1    36.3    -17%    141.6     160.6     -12%    \n South & West Europe  51.1    47.6    7%      258.5     216.4     19%     \n The Baltics          9.2     11.3    -19%    48.1      48.6      -1%     \n North America        66.6    46.1    44%     329.3     207.9     58%     \n South America        3.6     0.8     350%    18.7      3.9       379%    \n Asia-Pacific         24.1    27.4    -12%    117.2     118.4     -1%     \n Africa               2.1     1.9     11%     10.5      8.4       25%     \n Zinzino              312.2   273.7   14%     1,517.7   1,227.9   24%     \n Faun Pharma          3.9     3.9     0%      28.2      26.1      8%      \n Zinzino Group        316.1   277.6   14%     1,545.9   1,254.0   23%     \n\n \n\nCountries in regions:\n\n-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden\n\n-Central Europe: Austria, Germany, Switzerland\n\n-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania\n\n-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta,\nNetherlands, Slovenia, Portugal, Spain, United Kingdom, Belgium, Ireland,\nSerbia, Turkey, Canary Islands\n\n-The Baltics: Estonia, Latvia, Lithuania\n\n-North America: Canada, USA, Mexico\n\n-South America: Peru, Colombia\n\n-Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore,\nTaiwan, Thailand, China, Philippines, South Korea\n\n-Africa: South Africa\n\n \n\n \n\nFor more information:\n\nDag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com\n\nFredrik Nielsen CFO Zinzino +46 (0) 707 900 174, fredrik.nielsen@zinzino.com\n\n \n\nPictures for publication free of charge: marketing@zinzino.com\n\n \n\nCertified Adviser: Tapper Partners AB\n\nZinzino is a global health tech company from Scandinavia, pioneering a new\nstandard in personal health through advanced home health tests and\nscientifically proven nutritional supplements. Listed on the Nasdaq First\nNorth Premier Growth Market, the company's test-based, personalized nutrition\nstrategy empowers individuals to take charge of their long-term health with\nscience-based insights and targeted solutions. Its third-party validated\nproducts are available through direct sales distributors in more than 100\nmarkets worldwide. Zinzino's headquarters are located in Gothenburg, Sweden,\nwith additional offices across Europe, Asia, and Australia.\n\nhttps://news.cision.com/zinzino/r/zinzino-ab--publ--preliminary-sales-report-may-2026%2Cc4356932\n\n2605 Press release Sales report EN\n(https://mb.cision.com/Public/10976/4356932/abca147d59e4d6a7.pdf)\n\n\n\n(c) Copyright Waymaker BIT News - Cision 2026"},"type":"article","timestamp":"2026-06-03T07:00:16.085508732Z","server_sent_at_ms":1780470016085},"received_at":"2026-06-03T07:00:16.154Z","source_url":"https://news.cision.com/zinzino/r/zinzino-ab--publ--preliminary-sales-report-may-2026%2Cc4356932"},"analysis":{"id":"42619","press_release_id":"53186","analysis_json":{"industry":{"label":"Food, Beverage & Tobacco","sector":"Consumer Staples"},"redFlags":[],"eventType":"operations_update","narrative":"Zinzino reported May 2026 group revenue of SEK 316.1 million, a 14% increase year-over-year.\n\nAccumulated revenue for January through May 2026 reached SEK 1,545.9 million, up 23% from the same period last year.\n\nGrowth was driven by strong performance in North America (58% YTD growth), South America (379% YTD growth), and Central Europe (39% YTD growth), offsetting declines in the Nordics, East Europe, and Asia-Pacific.","sentiment":"bullish","agentHooks":{"shouldPost":false,"suggestedAngle":"Solid 23% YTD revenue growth driven by emerging markets, though mature regions like Nordics and Asia-Pacific are flat or declining."},"keyFigures":{"revenue":316100000,"revenueYoy":"14%","customDimensions":{"ytd_revenue_yoy":"23%","zinzino_revenue_may":312200000,"faun_pharma_revenue_may":3900000,"north_america_ytd_growth":"58%","south_america_ytd_growth":"379%","central_europe_ytd_growth":"39%"}},"quotedText":"Zinzino is a global health tech company from Scandinavia, pioneering a new standard in personal health through advanced home health tests and scientifically proven nutritional supplements.","namedEntities":{"people":[{"name":"Dag Bergheim Pettersen","role":"CEO"},{"name":"Fredrik Nielsen","role":"CFO"}],"products":[],"companies":[{"name":"Zinzino AB (publ)","ticker":"ZZB"},{"name":"Faun Pharma","relationship":"subsidiary"},{"name":"Tapper Partners AB","relationship":"certified adviser"}],"dollarAmounts":[{"amount":"SEK 316.1 million","context":"Group revenue May 2026"},{"amount":"SEK 277.6 million","context":"Group revenue May 2025"},{"amount":"SEK 1,545.9 million","context":"Accumulated revenue Jan-May 2026"},{"amount":"SEK 1,254.0 million","context":"Accumulated revenue Jan-May 2025"},{"amount":"SEK 312.2 million","context":"Zinzino sales markets revenue May 2026"},{"amount":"SEK 3.9 million","context":"Faun Pharma external sales May 2026"}]},"materialImpact":{"score":2,"reasoning":"Routine monthly sales report showing strong 14% YoY growth for May and 23% YTD growth. No guidance changes or strategic shifts, just operational performance data."},"tickerRelevance":{"others":[],"primary":"ZZB"},"globalImportance":15,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"routine_sales_report","sectorWeight":"low","householdBrandBoost":0,"marketCapAdjustment":"negative","retailFavoriteBoost":0}},"event_type":"operations_update","event_type_secondary":null,"sentiment":"bullish","material_impact_score":2,"narrative":"Zinzino reported May 2026 group revenue of SEK 316.1 million, a 14% increase year-over-year.\n\nAccumulated revenue for January through May 2026 reached SEK 1,545.9 million, up 23% from the same period last year.\n\nGrowth was driven by strong performance in North America (58% YTD growth), South America (379% YTD growth), and Central Europe (39% YTD growth), offsetting declines in the Nordics, East Europe, and Asia-Pacific.","key_figures":{"revenue":316100000,"revenueYoy":"14%","customDimensions":{"ytd_revenue_yoy":"23%","zinzino_revenue_may":312200000,"faun_pharma_revenue_may":3900000,"north_america_ytd_growth":"58%","south_america_ytd_growth":"379%","central_europe_ytd_growth":"39%"}},"named_entities":{"people":[{"name":"Dag Bergheim Pettersen","role":"CEO"},{"name":"Fredrik Nielsen","role":"CFO"}],"products":[],"companies":[{"name":"Zinzino AB (publ)","ticker":"ZZB"},{"name":"Faun Pharma","relationship":"subsidiary"},{"name":"Tapper Partners AB","relationship":"certified adviser"}],"dollarAmounts":[{"amount":"SEK 316.1 million","context":"Group revenue May 2026"},{"amount":"SEK 277.6 million","context":"Group revenue May 2025"},{"amount":"SEK 1,545.9 million","context":"Accumulated revenue Jan-May 2026"},{"amount":"SEK 1,254.0 million","context":"Accumulated revenue Jan-May 2025"},{"amount":"SEK 312.2 million","context":"Zinzino sales markets revenue May 2026"},{"amount":"SEK 3.9 million","context":"Faun Pharma external sales May 2026"}]},"model_name":"qwen3_6_27b_awq","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-06-04T04:50:57.451Z","global_importance":15,"audience_relevance":10,"importance_components":{"tickerTier":"small-cap","eventGravity":"routine_sales_report","sectorWeight":"low","householdBrandBoost":0,"marketCapAdjustment":"negative","retailFavoriteBoost":0}},"durationMs":69446,"modelName":"george-droid-qwen-72b"}}